MediciNova, Inc. is a biopharmaceutical company, which focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus. The company is headquartered in La Jolla, California and currently employs 13 full-time employees. The company went IPO on 2006-12-01. The firm's development activities are focused on MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, substance dependence and addiction (methamphetamine dependence, opioid dependence and alcohol dependence), prevention of acute respiratory distress syndrome, and Long COVID, and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease and hypertriglyceridemia. Its MN-166 (ibudilast) is a first-in-class, oral, anti-inflammatory and neuroprotective agent. The FDA has granted Fast Track designations to MN-166 (ibudilast) for three separate indications: progressive MS, ALS, and methamphetamine dependence.
How did MNOV's recent EPS compare to expectations?
The most recent EPS for MediciNova Inc is $-0.05, not beating expectations of $-0.09.
How did MediciNova Inc MNOV's revenue perform in the last quarter?
MediciNova Inc revenue for the last quarter is $-0.05
What is the revenue estimate for MediciNova Inc?
According to 5 of Wall street analyst, the revenue estimate of MediciNova Inc range from $136.5K to $0.0
What's the earning quality score for MediciNova Inc?
MediciNova Inc has a earning quality score of B+/45.56688. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does MediciNova Inc report earnings?
MediciNova Inc next earnings report is expected in 2026-06-08
What are MediciNova Inc's expected earnings?
MediciNova Inc expected earnings is $0.0, according to wall-street analysts.
Did MediciNova Inc beat earnings expectations?
MediciNova Inc recent earnings of $151.74K beat expectations.